NIH awards Dartmouth $18 million translational research grant

The National Institutes of Health’s (NIH’s) Center for Advancing Translational Sciences (NCATS) awarded $18 million to Dartmouth College in Hanover, N.H. to advance translational medicine.  

NIH’s Clinical and Translational Science Award (CTSA)—a five-year grant—will support healthcare innovation at Dartmouth and accelerate the CTSA Consortium's development of new treatments using the power of data, emerging technologies and collaboration across disciplines and institutions. Through the grant, dozens of U.S. medical research institutions can access data in the Dartmouth Atlas of Health Care project, according to an announcement.

Dartmouth is the sole new recipient of the CTSA grant this year, and joins 60 other institutions. As an award winner, CTSA Consortium’s other members can access the large population databases in the Dartmouth Atlas.

The $18 grant will be matched with $20 million from Dartmouth’s Geisel School of Medicine and the Dartmouth-Hitchcock health system for a total $38 million investment supporting translational science at Dartmouth College, Geisel School of Medicine, Dartmouth-Hitchcock and the Veterans Affairs Medical Center in White River Junction, Vt.

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.